Scopus BioPharma
is a biopharmaceutical company that delivers novel therapeutics targeting the body’s endocannabinoid system... Read moreScopus BioPharma
is a biopharmaceutical company that delivers novel therapeutics targeting the body’s endocannabinoid system... Read more
News
Nov 02, 2023
Benzinga
Scopus BioPharma: Scopus BioPharma's Subsidiary - Duet BioTherapeutics - to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
Oct 18, 2022
BioSpace
Scopus BioPharma: Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value
May 20, 2022
MarketScreener
Scopus BioPharma: Scopus BioPharma : Sydney, May 19, 2022 - Form 8-K
May 05, 2022
MarketScreener
Scopus BioPharma: Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
Jan 10, 2022
centralcharts
Press Release: Scopus BioPharma : Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
Jan 09, 2022
MarketScreener
Scopus BioPharma: Scopus BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K/A
Jan 06, 2022
PR Newswire
Press Release: Scopus BioPharma : DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS
Dec 28, 2021
Nasdaq
Scopus BioPharma: Scopus Biopharma Inc Shares Approach 52-Week Low - Market Mover
Dec 17, 2021
GlobeNewswire
Press Release: Scopus BioPharma : Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster's Campaign Against the Company
Dec 17, 2021
firstwordpharma
Scopus BioPharma: Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster's Campaign Against the Company
Scopus BioPharma Competitors
1
2
3
4
5
6
7
8
9
10